This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Editors' Note: Dr. Barrett et al. and author Willis discuss the limitations associated with using Medicare data in Parkinson disease research. Drs. Jung Henson and Cavalier disagree with some of the views presented in author Langer-Gould's editorial, “The pill times 2: What every woman with multiple sclerosis should know,” specifically as to the existence of human data into the teratogenicity of teriflunomide and the recommendation to stop the medication 2 years prior to conception. Author Langer-Gould responds with a discussion of the study in question and a review of the elimination methods for teriflunomide.—Megan Alcauskas, MD, and Robert C. Griggs, MD
As Willis et al. recognized, one of the major limitations of Medicare data are …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis
Prof. Massimo Filippi and Dr. Paolo Preziosa
► Watch
Alert Me
Recommended articles
A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease
Deep brain stimulation in early-stage Parkinson disease
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease